Investor profile
John Brenneman
An investor, John Brenneman has 4 known investments: Omeros, Caminova, Inc., Opticyte, Inc. and Ostex International.
Is John Brenneman a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
John Brenneman portfolio companies (4)
- Omeros
- Caminova, Inc.
- Opticyte, Inc.
- Ostex International
Investor Profile
The known portfolio sits in sector Healthcare, and focus areas Biopharma, Diagnostics, Medical Devices and Therapeutics.
Stage-wise, the known deals cluster around Late-Stage, Seed and Series A rounds.
Reviewing the investment history helps decide whether there is a realistic fit before reaching out.
Similar investors
Showing 20 of 100
Frequently asked questions
Who is John Brenneman?
John Brenneman is an investor with 4 known investments on file, among them Omeros, Caminova, Inc. and Opticyte, Inc. The sections above list the sectors and stages attached to that record.
What does John Brenneman invest in?
Listed sectors include Healthcare; listed focus areas include Biopharma, Diagnostics, Medical Devices and Therapeutics. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does John Brenneman invest at?
The known deals of John Brenneman include Late-Stage, Seed and Series A rounds. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
How do I contact John Brenneman?
An email address and a LinkedIn page are on file for John Brenneman. The address stays masked on this page and is readable inside RaiseHunt after you create an account. The database holds no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal
